Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort-Reference-Cited by-同舟云学术

Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort

Published:2017-01 Issue: Volume:247 Page:130-138
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Husa Anja P.,Moilanen Jani,Murray Graham K.,Marttila Riikka,Haapea Marianne,Rannikko Irina,Barnett Jennifer H.,Jones Peter B.,Isohanni Matti,Remes Anne M.,Koponen Hannu,Miettunen Jouko,Jääskeläinen Erika

Funder

Academy of Finland

Sigrid Jusélius Foundation

Brain & Behavior Research Foundation

Jalmari and Rauha Ahokas Foundation

Emil Aaltonen Foundation

Finnish Cultural Foundation Lapland Regional Fund

Northern Finland Health Care Support Foundation

UK Medical Research Council

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference60 articles.

1. Antipychotic drug effects in schizophrenia: a review of longitudinal fMRI investigations and neural interpretations;Abbott;Curr. Med. Chem.,2013

2. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am. J. Psychiatry,2005

3. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study;Andreasen;Am. J. Psychiatry,2013

4. Subjective response to neuroleptics in schizophrenia;Awad;Schizophr. Bull.,1993

5. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: Do the cognitive deficits progress over, or after, the onset of psychosis?;Bora;Schizophr. Bull.,2014

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive subgroups of affective and non-affective psychosis show differences in medication and cortico-subcortical brain networks;Scientific Reports;2024-09-02

2. Overlap between individual differences in cognition and symptoms of schizophrenia;Schizophrenia Research;2024-08

3. Enlarged pituitary gland volume: a possible state rather than trait marker of psychotic disorders;Psychological Medicine;2024-02-15

4. Perfil neuropsicológico en pacientes con esquizofrenia de acuerdo con el nivel de adherencia a la medicación;Revista iberoamericana de psicología;2024-02-08

5. Biomarkers of neurodegeneration in schizophrenia: systematic review and meta-analysis;BMJ Mental Health;2024-01